Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel

Farhad Ravandi*, Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie D Freeman, Christopher S Hourigan, Gerrit J Ossenkoppele, Gail J Roboz, Marion Subklewe, Christian Thiede, Isabell Arnhardt, Peter J M Valk, Adriano Venditti, Andrew H Wei, Roland B Walter, Michael Heuser*

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel'. Together they form a unique fingerprint.

    Medicine & Life Sciences